In addition, Terwijn et al (2014) showed that light scatter properties together with aberrant marker expression (including CLEC12A) on the CD34+CD38− cells were able to discriminate leukaemic and normal stem cell compartments in AML validated by xenograft studies. The gene discussed is CLEC12A; the disease is acute myeloid leukemia.